IU1 is a cell-permeable, reversible, and selective inhibitor of the proteasome-associated deubiquitinating enzyme USP14 (IC50 = 4.7 μM), with 25-fold selectivity over IsoT. It induces autophagy and enhances proteasomal degradation of ubiquitinated substrates such as Ub-CCNB. IU1 promotes the degradation of pathogenic proteins including tau, TDP-43, ATXN3, and glial fibrillary acidic protein (GFAP), making it a valuable tool for studying proteotoxic stress mechanisms and potential therapeutic strategies for neurodegenerative diseases.